Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.
You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!
If you have any problems with the registration process or your account login, please contact contact us.
Press Release from the Uniformed Services University: Novel Phytochemical Agent Enhances, Improves Process of Wound Healing
Quote:
BETHESDA, Md. — Researchers at the Uniformed Services University of the Health Sciences (USU)
have identified a novel phytochemical agent that enhances and improves the process of wound healing in
normal and immune compromised people.
In an article published in the March 2007 edition of the Journal Planta Medica, Dr. Radha
Maheshwari, professor of Pathology at USU, along with Anuj Sharma, graduate student and other
colleagues, reported a novel compound Picroliv obtained from the roots of a plant Picrorhiza kurrooa
enhances the rate of wound healing by principally enhancing the restoration of the blood supply to the
damaged tissue.
Previous work from Dr. Maheshwari’s laboratory has shown that Picroliv also protects from the
injuries induced by hypoxia and reoxygenation and upreulates the expression of vascular endothelial growth
factor in human umbilical vein endothelial cells and of insulin-like growth factor in rats during hypoxia.
These findings suggest that Picroliv could be developed as a therapeutic angiogenic agent for the restoration
of the blood supply in diseases involving inadequate blood supply such as limb ischemia, ischemic
myocardium and wound healing.
This work supported by funding from National Institutes of Health has important implications in
understanding the underlying process important for wound healing and developing agents that can enhance
these processes. Wounds and their treatment remain a major area of research for military combat causality
and civilian traumatic injuries and this research identifies a potential therapeutic compound that may be
developed for treatment of wounds.
Located on the grounds of Bethesda’s National Naval Medical Center and across from the National
Institutes of Health in Bethesda, Md, USU is the nation’s federal school of medicine and graduate school of
nursing. Students are active-duty uniformed officers in the Air Force, Army, Navy, and Public Health
Service, who are being educated to deal with wartime casualties, national disasters, emerging infectious
diseases, and other public health emergencies. The university conducts sponsored research in the combined
sciences, including military-relevant research in parasitology, infectious diseases, treatment of traumatic
injury, and other issues related to health, war, and national disaster.
Phytochemical Agent Improves Wound Healing
Linear Mode
